Argenx (ARGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter ...

US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase ...

Plans to develop S-1117 for treatment of wide array of IgG autoantibody-driven diseases, such as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy ... PhD, Chief Medical Officer and ...

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...

HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...

Gayle completed her earthly journey in the early morning hours of March 8 at Penn State St. Joseph Medical Center in Reading. Gayle was born in Palmerton, PA, the daughter of William E.

Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...

Get Instant Summarized Text (Gist) Isocyanic acid (ICA), a metabolite produced by the enzyme LACC1, has been identified as an anti-inflammatory agent. ICA disrupts NLRP3 inflammasome activation in ...

Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...